Yogendra Nayak

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 23

Top Venues

Manipal College of Pharmaceutical Sciences

Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Manipal College of Pharmaceutical Sciences Sep 12 2005

India

Associate Professor :: Pharmacology

Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences Jan 01 2003 - Sep 10 2005

India

Lecturer :: Department of Pharmacology

Biocon Ltd Mar 01 1999 - Mar 31 2000

India

Junior Production Executive :: Production

Education History

Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal Oct 24 2008 - Jun 07 2011

India

PHD :: Pharmacology

Publications

Varalakshmi Velagacherla, Yogendra Nayak, K Vijaya Bhaskar, Usha Yogendra Nayak
A stability indicating method development and validation of a rapid and sensitive RP-HPLC method for Nintedanib and its application in quantification of nanostructured lipid carriers. F1000Research 12 (2024)
Varalakshmi Velagacherla, Yogendra Nayak, K Vijaya Bhaskar, Usha Yogendra Nayak
A stability indicating method development and validation of a rapid and sensitive RP-HPLC method for Nintedanib and its application in quantification of nanostructured lipid carriers. F1000Research 12 (2024)
Nikitha Naomi Dsouza, Varun Alampady, Krishnaprasad Baby, Swastika Maity, Bharath Harohalli Byregowda, Yogendra Nayak
Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis. Inflammopharmacology (2023)
Krishnaprasad Baby, Swastika Maity, Chetan Hasmukh Mehta, Usha Y Nayak, Gautham G Shenoy, Karkala Sreedhara Ranganath Pai, Kuzhuvelil B Harikumar, Yogendra Nayak
Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer. Scientific reports 13 (1) (2023)
Varalakshmi Velagacherla, Akhil Suresh, Chetan Hasmukh Mehta, Usha Yogendra Nayak, Yogendra Nayak
Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment. Viruses 15 (1) (2023)
Krishnaprasad Baby, Swastika Maity, Chetan Hasmukh Mehta, Usha Y Nayak, Gautham G Shenoy, Karkala Sreedhara Ranganath Pai, Kuzhuvelil B Harikumar, Yogendra Nayak
Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer. Scientific reports 13 (1) (2023)
Ashwini T, Ashlesh Prabhu, Vishal Baliga, Shreesha Bhat, Siddarth T Thenkondar, Yogendra Nayak, Usha Yogendra Nayak
Transforming Wound Management: Nanomaterials and Their Clinical Impact. Pharmaceutics 15 (5) (2023)
Swastika Maity, Jaya Aakriti, Suman Manandhar, Sharad B Anchan, Ashlesh Bhat, Mayur U Shetty, Yogendra Nayak
Emvolio - A battery operated portable refrigerator preserves biochemical and haematological integrity of biological samples in preclinical studies. F1000Research 11 (2023)
Takkella Nagamma, Anjaneyulu Konuri, Kumar M R Bhat, Padmanabha E G Udupa, Yogendra Nayak
Trigonella foenum-graecum L. seed extract modulates biochemical and histomorphological changes in therapeutic model of high-fat diet-fed ovariectomized rats. 3 Biotech 13 (8) (2023)
Varalakshmi Velagacherla, Akhil Suresh, Chetan Hasmukh Mehta, Usha Yogendra Nayak, Yogendra Nayak
Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment. Viruses 15 (1) (2023)
Suggala Ramya Shri, Suman Manandhar, Yogendra Nayak, Karkala Sreedhara Ranganath Pai
Role of GSK-3β Inhibitors: New Promises and Opportunities for Alzheimer's Disease. Advanced pharmaceutical bulletin 13 (4) (2023)
Nikitha Naomi Dsouza, Varun Alampady, Krishnaprasad Baby, Swastika Maity, Bharath Harohalli Byregowda, Yogendra Nayak
Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis. Inflammopharmacology (2023)
Varalakshmi Velagacherla, Akhil Suresh, Chetan Hasmukh Mehta, Usha Yogendra Nayak, Yogendra Nayak
Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment. Viruses 15 (1) (2023)
Varalakshmi Velagacherla, Akhil Suresh, Chetan Hasmukh Mehta, Usha Yogendra Nayak, Yogendra Nayak
Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment. Viruses 15 (1) (2023)
Varalakshmi Velagacherla, Akhil Suresh, Chetan Hasmukh Mehta, Usha Yogendra Nayak, Yogendra Nayak
Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment. Viruses 15 (1) (2023)
Krishnaprasad Baby, Swastika Maity, Chetan Hasmukh Mehta, Usha Y Nayak, Gautham G Shenoy, Karkala Sreedhara Ranganath Pai, Kuzhuvelil B Harikumar, Yogendra Nayak
Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer. Scientific reports 13 (1) (2023)
Takkella Nagamma, Anjaneyulu Konuri, Kumar M R Bhat, Rajalekshmi Maheshwari, Padmanabha Udupa, Yogendra Nayak
Modulation of inflammatory markers by petroleum ether fraction of Trigonella foenum-graecum L. seed extract in ovariectomized rats. Journal of food biochemistry 45 (4) (2021)
Rania Hamdy, Bahgat Fayed, Ahmed Mostafa, Noura M Abo Shama, Sara Hussein Mahmoud, Chetan Hasmukh Mehta, Yogendra Nayak, Sameh S M Soliman
Iterated Virtual Screening-Assisted Antiviral and Enzyme Inhibition Assays Reveal the Discovery of Novel Promising Anti-SARS-CoV-2 with Dual Activity. International journal of molecular sciences 22 (16) (2021)
Krishnaprasad Baby, Swastika Maity, Chetan H Mehta, Akhil Suresh, Usha Y Nayak, Yogendra Nayak
Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19. F1000Research 9 (2020)
Shivaprasad Gadag, Shristi Sinha, Yogendra Nayak, Sanjay Garg, Usha Yogendra Nayak
Combination Therapy and Nanoparticulate Systems: Smart Approaches for the Effective Treatment of Breast Cancer. Pharmaceutics 12 (6) (2020)
Swastika Maity, Karkala Sreedhara Ranganath Pai, Yogendra Nayak
Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance. Pharmacological reports : PR 72 (4) (2020)
Anand M Bokare, Mandar Bhonde, Rajan Goel, Yogendra Nayak
5-HT6 receptor agonist and antagonist modulates ICV-STZ-induced memory impairment in rats. Psychopharmacology 235 (5) (2018)
Anand M Bokare, A K Praveenkumar, Mandar Bhonde, Yogendra Nayak, Ravindra Pal, Rajan Goel
5-HT6 Receptor Agonist and Antagonist Against β-Amyloid-Peptide-Induced Neurotoxicity in PC-12 Cells. Neurochemical research 42 (5) (2017)
Yogendra Nayak, Venkatachalam Hillemane, Vijay Kumar Daroji, B S Jayashree, M K Unnikrishnan
Antidiabetic activity of benzopyrone analogues in nicotinamide-streptozotocin induced type 2 diabetes in rats. TheScientificWorldJournal 2014 (2014)

Yogendra Nayak.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yogendra Nayak